Mary Fisher

Chief Operating Officer, Acorda Therapeutics.

Companies

Dermata Therapeutics, Inc.Board member Aug 12, 2021 to now¹
Sientra (United States)Board member Jan 10, 2019 to Jun 20, 2023²
Tempest Therapeutics, Inc.Board member Jun 11, 2013 to Dec 11, 2018³
Acorda TherapeuticsChief operating officer Feb 9, 2006 to Jul 5, 2007⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Dermata Therapeutics, Inc. DRMA196,946 shares⁵$172.2K at $0.87Jan 21, 2025
Sientra (United States)19,581 shares⁶Jun 15, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 21, 2025Granted 196,851 shares of Dermata Therapeutics, Inc.⁵
Jun 15, 2023Granted 12,000 shares of Sientra (United States)⁶
Oct 6, 2022Granted 9,810 shares of Dermata Therapeutics, Inc.⁷
Jul 7, 2022Granted 8,602 shares of Dermata Therapeutics, Inc.⁸
Jun 9, 2022Granted 103,306 shares of Sientra (United States)⁹
Apr 7, 2022Granted 5,031 shares of Dermata Therapeutics, Inc.¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDermata Therapeutics, Inc., Board member
2
SEC EDGARSientra (United States), Board member
3
SEC EDGARTempest Therapeutics, Inc., Board member
4
SEC EDGARAcorda Therapeutics, Chief operating officer
5
SEC EDGARDermata Therapeutics, Inc. shares after the filing of Jan 21, 2025
6
SEC EDGARSientra (United States) shares after the filing of Jun 15, 2023
7
SEC EDGARForm 4 filed Oct 7, 2022
8
SEC EDGARForm 4 filed Jul 8, 2022
9
SEC EDGARForm 4 filed Jun 13, 2022
10
SEC EDGARForm 4 filed Apr 8, 2022